Dyslipidemias - Clinical Features and Management Flashcards

1
Q

Lipid hypothesis:

A

-elevated serum cholesterom levels directly linked to atherosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Major modifiable risk factors for atherosclerosis:

A
  • smoking
  • diabetes mellitus
  • HTN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

intensity of ASCVD-preventative therapy is based on:

A

-serum lipid levels AND risk factors!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Non drug treatment:

A
  • diet mod
  • regular exercise
  • attain and maintain optimum weight
  • not smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

High Total cholesterol level

A

260<

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hgih LDL-C level?

A

160<

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which diet works well for high LDL-C diet?

A

DASH DIET (dietary approach to stop hypertension)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the target level for LDL-C treatment?

A

there is no level anymore - we match the intensity of preventative treatment to absolute individual risk of ASCVD over 10 year period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Drug of choice for cholesterol dyslipidemias?

A

-STATINS - HMG-CoA reductase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Benefit to using statis?

A
  • reduce LDL and TG
  • increase HDL
==> reduce major coronary events
==>reduce CAD mortality
==>reduce coronary procedures
==> reduce stroke
==> reduce total mortality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Major side effects to statins:

A
  • myopathy

- inc liver enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Contraindication to statins?

A

-liver disease!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

4 major statin benefit groups:

A

1) secondary prevention - clinical ASCVD
2) Primary prevention-individuals with pimary LDL elevation >190
3) Primary prevention-diabetics 40-75yo and LDL level 70-189
4) primary prevention-without diabetes but estimated 10-year CVD risk>=7.5%, age 40-75 with LDL 70-189

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What to give patients with ASCVD (CHD, nonfatal MI< stroke..etc) and=7.5%?

A

HIGH INTENSITY STATIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Do not use statin therapy for people with:

A

heart failure class 2-4 and people on maintenance hemodialysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

If 21yr or older patient with just LDL>=190 but no clinical ASCVD - what to do?

A

just need to start on hgih intensity statin

17
Q

If 21yo without diabetes and LDL-C 70-189 with estimated 10yr risk of 7.5% of greater-what to do?

A

-mod or high intensity statin

18
Q

Less than 75 with no safety concerns but has clinical ASCVD - what to do?

A

high intensity statin (secondary prevention)

19
Q

Older than 75 with safety concerns and clinical ASCVD - what to do?

A

moderate intensity statin (secondary prevention)

20
Q

LDL-C>=190 but no clinical ASCVD - what to do?

A

(primary prevention)

  • look for secondary causes of dyslipidemias
  • high intensity statin
  • try to reduce LDL-C by more than 50%
  • LDL-C non statin therapy
21
Q

high intensity statins:

A

Atorvastatin

rosuvastatin

22
Q

Moderate intensity statins:

A
atorvastatin
rosuvastatin
simvastatin
pravastatin
lovastatin
23
Q

Low intensity statins:

A

pravastatin

lovastatin

24
Q

Bile acid sequestrants

  • major actions
  • side effects
A

1) reduce LDL 15-30%
- raise HDL 3-5%
- may inc TG
2) -GI issues
- dec absorption of other drugs

25
Q

Bile acid sequestrants

-contrainications:

A
  • hgih TGs

- dysbetalipoproteinemia

26
Q

Bile acid sequestrant drugs:

A
  • cholestyramine
  • cholestipol
  • colesevelam
27
Q

Bile acid sequestrants - benefits:

A
  • reduce major coronary events

- reduce CAD mortality

28
Q

nicotinic acid

  • major actions
  • side effects:
A

1) lowers LDL 5-25%
-lowers TG20-50%
-raises HDL 15-35%
2) flushing
hyperglycemia
hyperuricemia
upper GI distress
liver tox

29
Q

(NIACIN) nicotinic acid -contraindications:

A
  • liver disease
  • severe gout
  • peptic ulcer
30
Q

nicotinic acid - benefits:

A
  • reduces major coronary events

- possible reduction in total mortality

31
Q

fibric acid derivatives:

  • used for?
  • actions?
A
  • mostly used for hyperTGs
  • lower LDL 5-20% (if nml TG)
  • may raise LDL (if high TG)
  • lower TG 20-50%
  • raise HDL 10-20%
32
Q

Fibric acids

  • side effects:
  • contraindications:
A

1) dyspepsia
gallstones
myopathy
2) Severe renal or hepatic disease

33
Q

fibric acids therapeutic bebefits:

A
  • reduce progression of coronary lesions

- reduce major coronary events